Evidence map›Paper›PMID 26105054›Full record

ArticleThe Journal of biological chemistry2015

The Activation Pathway of Human Rhodopsin in Comparison to Bovine Rhodopsin.

Roman Kazmin, Alexander Rose, Michal Szczepek, Matthias Elgeti, Eglof Ritter, Ronny Piechnick, Klaus Peter Hofmann, Patrick Scheerer, Peter W Hildebrand, Franz J Bartl

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Glu102Biochemistry · 2024
    Article
  5. Article
  6. The Luminescence Hypothesis of Olfaction.Sensors (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Roman KazminFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, Institut für Biologie, Experimentelle Biophysik, Humboldt-Universität zu Berlin, 10115 Berlin, Germany, and.
Alexander RoseFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, AG ProteInformatics, Charitéplatz 1, 10117 Berlin, Germany.
Michal SzczepekFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, AG Protein X-ray Crystallography and Signal Transduction, and.
Matthias ElgetiFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin.
Eglof RitterInstitut für Biologie, Experimentelle Biophysik, Humboldt-Universität zu Berlin, 10115 Berlin, Germany, and eglof.ritter@hu-berlin.de.
Ronny PiechnickFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin.
Klaus Peter HofmannFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, Zentrum für Biophysik und Bioinformatik (BPI), Humboldt-Universität zu Berlin, 10115 Berlin, Germany.
Patrick ScheererFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, AG Protein X-ray Crystallography and Signal Transduction, and patrick.scheerer@charite.de.
Peter W HildebrandFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, AG ProteInformatics, Charitéplatz 1, 10117 Berlin, Germany.
Franz J BartlFrom the Institut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, franz.bartl@charite.de.
Charité - Universitätsmedizin Berlin · DEHumboldt-Universität zu Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhodopsin, the photoreceptor of rod cells, absorbs light to mediate the first step of vision by activating the G protein transducin (Gt). Several human diseases, such as retinitis pigmentosa or congenital night blindness, are linked to rhodopsin malfunctions. Most of the corresponding in vivo studies and structure-function analyses (e.g. based on protein x-ray crystallography or spectroscopy) have been carried out on murine or bovine rhodopsin. Because these rhodopsins differ at several amino acid positions from human rhodopsin, we conducted a comprehensive spectroscopic characterization of human rhodopsin in combination with molecular dynamics simulations. We show by FTIR and UV-visible difference spectroscopy that the light-induced transformations of the early photointermediates are very similar. Significant differences between the pigments appear with formation of the still inactive Meta I state and the transition to active Meta II. However, the conformation of Meta II and its activity toward the G protein are essentially the same, presumably reflecting the evolutionary pressure under which the active state has developed. Altogether, our results show that although the basic activation pathways of human and bovine rhodopsin are similar, structural deviations exist in the inactive conformation and during receptor activation, even between closely related rhodopsins. These differences between the well studied bovine or murine rhodopsins and human rhodopsin have to be taken into account when the influence of point mutations on the activation pathway of human rhodopsin are investigated using the bovine or murine rhodopsin template sequences.

Indexed as

Amino Acid SequenceAnimalsCattleHumansMolecular Dynamics SimulationMolecular Sequence DataRhodopsinSequence Homology, Amino AcidSpectroscopy, Fourier Transform InfraredRhodopsinG protein-coupled receptor (GPCR)humanprotein dynamicreceptorrhodopsinstructure-function

Identifiers

PMID26105054
PMCPMC4536423
OpenAlexW1903004145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.